Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasmodium Immunotherapy in Advanced NSCLC
NCT02786589Phase 2Unknown
- Sponsor
- State Key Laboratory of Respiratory Disease
- Start
- Jun 2016
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
A Phase 2 trial of plasmodium vivax in non-small cell lung cancer (NSCLC), sponsored by State Key Laboratory of Respiratory Disease. Status: unknown.
02
Drugs
plasmodium vivax
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02786589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786589.